The Annual Pharmaceutical and Medical Device Compliance Congress is an important opportunity for industry compliance professionals and regulators to exchange information and learn from one another. This year was no exception and this article briefly recaps the highlights from the conference’s first day.
Seventeen years have passed since the Pharmaceutical Compliance Forum held its first Compliance Congress. Now with over 350 attendees, the Congress, held this October in Washington, DC, 1 continues the tradition of being an excellent opportunity for networking, transformational learning, and “effective knowledge exchange.” 2
Following the traditional format, the Day 1 plenary session focused on the “hot topics” the continue to occupy the attention of life science compliance professionals. These sessions included:
• The Chief Compliance Officer Roundtable
• The FCPA Enforcement Panel
• Annual OIG Update
Read Full Article in the December 2016 Issue of Life Science Compliance Update